Third Party Performance Data
To confirm reproducibility and robustness, Trenchant collaborated with Invetech, a global leader in advanced therapy manufacturing and product development, to perform testing using the identical Trenchant prototype platform, cassettes, and protocols.
Study Design
Invetech conducted three process runs with the assistance of Trenchant at Invetech laboratories using fresh human apheresis sourced from healthy donors. All critical unit operations—washing, selection, activation, and transduction were evaluated under controlled laboratory conditions.
Third Party Performance Results
Apheresis Wash Recovery
94.3%
Mean T-cell recovery
Single-step T-cell Selection & Activation Recovery
96.4%
Mean T-cell recovery
98.4%
Mean T-cell purity
Lentiviral Transduction Efficiency
73.6%
Mean GFP-positive cells